Expectant management of severe preeclampsia remote from term

Clinical Obstetrics and Gynecology

Volumn 42, Issue 3, 1999, Pages 470-478

  Friedman, Steven A ^a   Schiff, Eyal ^b   Lubarsky, Suzanne L ^a   Sibai, Baha M ^c,d  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d Dept of Obstetrics and Gynecology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIAZEPAM; GLUCOCORTICOID; HYDRALAZINE; LABETALOL; MAGNESIUM SULFATE; MISOPROSTOL; NIFEDIPINE; OXYTOCIN; PARACETAMOL; PHENOBARBITAL; PROSTAGLANDIN; PROSTAGLANDIN E2; RINGER LACTATE SOLUTION; SODIUM;

BED REST; DELIVERY; ECLAMPSIA; FEMALE; HUMAN; PATIENT SELECTION; PRACTICE GUIDELINE; PREECLAMPSIA; PREGNANCY COMPLICATION; REVIEW; SODIUM RESTRICTION; TREATMENT INDICATION;

FEMALE; GESTATIONAL AGE; HELLP SYNDROME; HUMANS; PRE-ECLAMPSIA; PREGNANCY; TREATMENT OUTCOME;

EID: 0033394682     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-199909000-00005     Document Type: Review

References (23)

1. Saftlas AF, Olson DR, Franks AL, Atrash HK, Pokras R. Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986. Am J Obstet Gynecol. 1990; 163:460-465.
2. Rochat RW, Koonin LM, Atrash HK, Jewett JF. Maternal mortality in the United States. Obstet Gynecol. 1988;72:91-97.
3. Plouin PF, Chatellier G, Breart G, Blot P, Ioan A, Azoulay M. Frequency and perinatal consequences of hypertensive disease of pregnancy. Adv Nephrol. 1986; 15:57-69.
4. American College of Obstetricians and Gynecologists. Hypertension in pregnancy. Washington: The College, 1996. Technical Bulletin No.: 219.
5. Martin TR, Tupper WRC. The management of severe toxemia in patients at less than 36 weeks' gestation. Obstet Gynecol. 1979;54: 602-605.
6. Sibai BM, Taslimi M, Abdella TN, Brooks TF, Spinnato JA, Anderson GD. Maternal and perinatal outcome of conservative management of severe preeclampsia in midtrimester. Am J Obstet Gynecol. 1985;152: 32-37.
7. Odendaal HJ, Pattinson RC, du Toit R. Fetal and neonatal outcome in patients with severe preeclampsia before 34 weeks. S Afr Med J. 1987;71:555-558.
8. Pattinson RC, Odendaal HJ, du Toit R. Conservative management of severe proteinuric hypertension before 28 weeks' gestation. S Afr Med J. 1988;73:516-518.
9. Visser W, van Pampus MG, Treffers PE, Wallenburg HCS. Perinatal results of hemodynamic and conservative temporizing treatment in severe preeclampsia. Eur J Obstet Gynecol Reprod Biol. 1994;53:175-181.
10. Visser W, Wallenburg HCS. Maternal and perinatal outcome of temporizing management in 254 consecutive patients with severe preeclampsia remote from term. Eur J Obstet Gynecol Reprod Biol. 1995;63:147-154.
11. Moodley J, Koranteng SA, Rout C. Expectant management of early onset of severe preeclampsia in Durban. S Afr Med J. 1993;83:584-587.
12. Cunningham FG, MacDonald PC, Gant NF, Leveno KJ, Gilstrap LC III. Williams obstetrics. 19th ed. Norwalk, CT: Appleton & Lange, 1993.
13. Stevenson DK, Wright LL, Lemons JA, et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1993 through December 1994. Am J Obstet Gynecol. 1998;179: 1632-1639.
14. Odendaal HJ, Pattinson RC, Bam R, Grove D, Kotze TJvW. Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks' gestation: A randomized controlled trial. Obstet Gynecol. 1990;76:1070-1075.
15. Sibai BM, Mercer BM, Schiff E, Friedman SA. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. Am J Obstet Gynecol. 1994;171:818-822.
16. Sibai BM, Akl S, Fairlie F, Moretti M. A protocol for managing severe preeclampsia in the second trimester. Am J Obstet Gynecol. 1990;163:733-738.
17. Fenakel K, Fenakel G, Appelman Z, Lurie S, Katz Z, Shoham (Schwartz) Z. Nifedipine in the treatment of severe preeclampsia. Obstet Gynecol. 1991;77:331-337.
18. Friedman SA, Taylor RN, Roberts JM. Pathophysiology of preeclampsia. Clin Perinatol. 1991;18:661-682.
19. Visser W, Wallenburg HCS. Temporizing management of severe preeclampsia with and without the HELLP syndrome. Br J Obstet Gynaecol. 1995;102:111-117.
20. Schiff E, Friedman SA, Kao L, Sibai BM. The importance of urinary protein excretion during conservative management of severe preeclampsia. Am J Obstet Gynecol. 1996; 175:1313-1316.
21. Chari RS, Friedman SA, O'Brien JM, Sibai BM. Daily antenatal testing in women with severe preeclampsia. Am J Obstet Gynecol. 1995;173:1207-1210.
22. Schucker JL, Mercer BM, Audibert F, Lewis RL, Friedman SA, Sibai BM. Serial amniotic fluid index in severe preeclampsia: A poor predictor of adverse outcome. Am J Obstet Gynecol. 1996;175:1018-1023.
23. Chua S, Redman CWG. Prognosis for preeclampsia complicated by 5 g or more of proteinuria in 24 hours. Eur J Obstet Gynecol Reprod Biol. 1992;43:9-12.